MORPHOLOGICAL AND FUNCTIONAL POLYMORPHISM WITHIN CLONAL THYROID-NODULES

被引:73
作者
AESCHIMANN, S
KOPP, PA
KIMURA, ET
ZBAEREN, J
TOBLER, A
FEY, MF
STUDER, H
机构
[1] UNIV BERN, INSELSPITAL, MED KLIN, INST MED ONCOL, CH-3010 BERN, SWITZERLAND
[2] TIEFENAU HOSP BERN, CLIN & EXPTL RES LAB, BERN, SWITZERLAND
[3] INSELSPITAL BERN, CENT HAEMATOL LAB, CH-3010 BERN, SWITZERLAND
[4] INSELSPITAL BERN, DEPT INTERNAL MED, EXPTL ENDOCRINOL LABS, CH-3010 BERN, SWITZERLAND
关键词
D O I
10.1210/jc.77.3.846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thirty-nine thyroid nodules, removed because of recent growth, were analyzed morphologically by serial histological sections for the classical histomorphological hallmarks of follicular cell replication and for immunohistochemically demonstrable overexpression of the growth-associated ras-gene product p21ras. Clonal analysis was performed using the highly informative probe M27beta that detects polymorphisms on the locus DXS255 of the X-chromosome. Twenty-four nodules were of clonal and 15 nodules were of polyclonal origin. Only 3 out of the 24 clonal nodules were histomorphologically uniform. In all others, the structural hallmarks of active growth and the P21ras growth-marker expression were remarkably heterogeneous throughout the tumors. There were no histomorphological characteristics distinguishing these clonal tumors from polyclonal nodules. Even if a clonal thyroid tumor may be originally homogeneous in respect to the parameters studied here, mechanisms must exist that create wide heterogeneity of growth and of morphogenetic potential among the individual follicular cells during further expansion of the nodule. Thus, clonal nodules are much more common in nodular goiters than hither-to assumed on grounds of the classical morphological criteria. The diagnosis of a true monoclonal nodule can no longer rely on morphological and functional criteria alone but requires molecular or cytogenetic analysis of clonality.
引用
收藏
页码:846 / 851
页数:6
相关论文
共 54 条
  • [1] AEBI U, 1991, PROGRESS IN THYROID RESEARCH, P679
  • [2] AESCHIMANN S, 1992, J ENDOCRINOL INVEST, V15, P85
  • [3] RAS ONCOGENES - THEIR ROLE IN NEOPLASIA
    BARBACID, M
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (03) : 225 - 235
  • [4] BOS JL, 1989, CANCER RES, V49, P4682
  • [5] TUMORIGENIC TRANSFORMATION OF MAMMALIAN-CELLS INDUCED BY A NORMAL HUMAN-GENE HOMOLOGOUS TO THE ONCOGENE OF HARVEY MURINE SARCOMA-VIRUS
    CHANG, EH
    FURTH, ME
    SCOLNICK, EM
    LOWY, DR
    [J]. NATURE, 1982, 297 (5866) : 479 - 483
  • [6] CIN, 1992, CANCER GENET CYTOGEN, V60, P99
  • [7] INTERCELLULAR PROPAGATION OF INDIVIDUALLY PROGRAMMED GROWTH BURSTS IN FRTL-5 CELLS - IMPLICATIONS FOR INTERPRETING GROWTH-FACTOR ACTIONS
    DERWAHL, M
    STUDER, H
    HUBER, G
    GERBER, H
    PETER, HJ
    [J]. ENDOCRINOLOGY, 1990, 127 (05) : 2104 - 2110
  • [8] CONTROL OF THYROID-CELL PROLIFERATION AND GOITROGENESIS
    DUMONT, JE
    MAENHAUT, C
    LAMY, F
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1992, 3 (01) : 12 - 17
  • [9] FARBER E, 1991, CANCER RES, V51, P2751
  • [10] CLONAL ANALYSIS OF HUMAN TUMORS WITH M27-BETA, A HIGHLY INFORMATIVE POLYMORPHIC-X CHROMOSOMAL PROBE
    FEY, MF
    PETER, HJ
    HINDS, HL
    ZIMMERMANN, A
    LIECHTIGALLATI, S
    GERBER, H
    STUDER, H
    TOBLER, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) : 1438 - 1444